You are here

FDA Reporting for GlaxoSmithKline

GSK sustained a process of data acquisition that encompassed two days of dedicated effort to produce a formatted report included in a Federal Drug Administration submission kit. This process involved running multiple reports, extrapolating the data into a Microsoft Word-friendly format, and finalizing the finished product with individual data points from a windows client.


Innovent Solutions worked closely with the GSK to create a flexible, easily maintainable solution that could be applied not only to current projects but anyfuture expansion of data delivery.


The results for the client were dramatic. A process that normally took a total of 6400 man-hours—at a staggering cost of $320,000 per year, now takes less than an hour per run. The savings to the client is estimated at approximately $300,000 per year.

Click here to read the full story (pdf).


More News